Wasatch Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-8,000
Closed -$1.35M 308
2018
Q1
$1.35M Sell
8,000
-11,231
-58% -$1.88M 0.02% 243
2017
Q4
$3.15M Hold
19,231
0.04% 184
2017
Q3
$3.94M Hold
19,231
0.05% 180
2017
Q2
$4.67M Sell
19,231
-2,954
-13% -$694K 0.07% 170
2017
Q1
$5.3M Hold
22,185
0.08% 158
2016
Q4
$4.66M Buy
+22,185
New +$4.6M 0.07% 174

Other funds holding AGN

Wasatch Advisors's AGN Position: Q2 2018 in Review

Wasatch Advisors sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 8,000 shares — an estimated $1.35M sold.

Wasatch Advisors first reported a position in AGN in Q4 2016 and held it in 6 quarters. The position peaked at $5.3M in Q1 2017. 1,043 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

  • Wasatch Advisors reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
  • Wasatch Advisors sold 8,000 Allergan plc shares in Q2 2018, an estimated $1.35M.
  • Wasatch Advisors first reported a position in Allergan plc in Q4 2016 and held it in 6 quarters.
  • Wasatch Advisors's Allergan plc position peaked at $5.3M in Q1 2017.
  • 1,043 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Wasatch Advisors's 13F filing for Q2 2018, filed 2 Aug 2018.